Literature DB >> 29445890

Benign endometrial proliferations mimicking malignancies: a review of problematic entities in small biopsy specimens.

Philip Pun-Ching Ip1.   

Abstract

Benign proliferations that mimic malignancies are commonly encountered during the course of assessment of small and fragmented endometrial samples. Although benign, endometrial epithelial metaplasias often coexist with premalignant or malignant lesions causing diagnostic confusion. The difficulty with mucinous metaplasia lies in its distinction from atypical mucinous glandular proliferations and mucinous carcinomas, which are associated with significant interobserver variability. Papillary proliferation of the endometrium is commonly associated with hormonal drugs and endometrial polyps and is characterised by papillae with fibrovascular cores covered by epithelial cells without cytologic atypia. They are classified into simple or complex papillary proliferations depending on the architectural complexity and extent of proliferation. Complex papillary proliferations are associated with a high risk of concurrent or subsequent hyperplasia with atypia/carcinoma. Papillary proliferations may have coexisting epithelial metaplasias and, most commonly, mucinous metaplasia and syncytial papillary change. Those with striking mucinous metaplasia overlap morphologically with papillary mucinous metaplasia. The latter has been proposed as a precursor of endometrial mucinous carcinoma. Misinterpreting the Arias-Stella reaction as a malignant or premalignant lesion is more likely to occur if the pathologist is unaware that the patient is pregnant or on hormonal drugs. Endometrial hyperplasia with secretory changes may occasionally be difficult to distinguish from the torturous and crowded glands of a late secretory endometrium. Endometrial polyps may have abnormal features that can be misinterpreted as endometrial hyperplasia or Mullerian adenosarcoma. Awareness of these benign endometrial proliferations and their common association with hormonal medication or altered endogenous hormonal levels will help prevent the over-diagnosis of premalignant and malignant lesions.

Entities:  

Keywords:  Arias-Stella reaction; Endometrial hyperplasia; Endometrial polyp; Endometrium; Mucinous; Mucinous metaplasia; Mullerian adenosarcoma; Papillary proliferation

Mesh:

Year:  2018        PMID: 29445890     DOI: 10.1007/s00428-018-2314-4

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  50 in total

1.  Uterine Endometrioid Carcinoma with Small Nonvillous Papillae: An Analysis of 26 Cases of a Favorable-Prognosis Tumor To Be Distinguished from Serous Carcinoma.

Authors:  Shawn K. Murray; Robert H. Young; Robert E. Scully
Journal:  Int J Surg Pathol       Date:  2000-10       Impact factor: 1.271

2.  Endometrial polyps with atypical (bizarre) stromal cells.

Authors:  Lisa H Tai; Fattaneh A Tavassoli
Journal:  Am J Surg Pathol       Date:  2002-04       Impact factor: 6.394

3.  Tripolar mitotic figures occurring in an Arias-Stella reaction within an endocervical polyp.

Authors:  C J McCormick; R A Menai-Williams
Journal:  Histopathology       Date:  1995-06       Impact factor: 5.087

4.  Mitoses in the Arias-Stella reaction.

Authors:  S Lipper; J D Benson
Journal:  Arch Pathol Lab Med       Date:  1981-02       Impact factor: 5.534

5.  Tamoxifen and the endometrium: review of 102 cases and comparison with HRT-related and non-HRT-related endometrial pathology.

Authors:  M M Kennedy; C F Baigrie; S Manek
Journal:  Int J Gynecol Pathol       Date:  1999-04       Impact factor: 2.762

6.  Papillary proliferation of the endometrium: a clinicopathologic study of 59 cases of simple and complex papillae without cytologic atypia.

Authors:  Philip P C Ip; Julie A Irving; W Glenn McCluggage; Philip B Clement; Robert H Young
Journal:  Am J Surg Pathol       Date:  2013-02       Impact factor: 6.394

7.  Villoglandular adenocarcinoma of the endometrium: a clinicopathologic study of 61 cases: a gynecologic oncology group study.

Authors:  R J Zaino; R J Kurman; V L Brunetto; C P Morrow; R C Bentley; J O Cappellari; P Bitterman
Journal:  Am J Surg Pathol       Date:  1998-11       Impact factor: 6.394

8.  Endometrial epithelial metaplasias: proliferations frequently misdiagnosed as adenocarcinoma. Report of 89 cases and proposed classification.

Authors:  M R Hendrickson; R L Kempson
Journal:  Am J Surg Pathol       Date:  1980-12       Impact factor: 6.394

9.  Proliferative mucinous lesions of the endometrium: analysis of existing criteria for diagnosing carcinoma in biopsies and curettings.

Authors:  Russell Vang; Fattaneh A Tavassoli
Journal:  Int J Surg Pathol       Date:  2003-10       Impact factor: 1.271

10.  Positive predictive value of endometrial polyps in Pipelle aspiration sampling: a histopathological study of 195 cases.

Authors:  Mimi T Y Seto; Philip P C Ip; Siew-Fei Ngu; Annie N Y Cheung; Ting-Chung Pun
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2016-04-30       Impact factor: 2.435

View more
  2 in total

Review 1.  [Current WHO classification of the female genitals : Many new things, but also some old].

Authors:  Doris Mayr; Elisa Schmoeckel; Anne Kathrin Höhn; Grit Gesine Ruth Hiller; Lars-Christian Horn
Journal:  Pathologe       Date:  2021-04-06       Impact factor: 1.011

2.  Clinical validation of a next-generation sequencing-based multi-cancer early detection "liquid biopsy" blood test in over 1,000 dogs using an independent testing set: The CANcer Detection in Dogs (CANDiD) study.

Authors:  Andi Flory; Kristina M Kruglyak; John A Tynan; Lisa M McLennan; Jill M Rafalko; Patrick Christian Fiaux; Gilberto E Hernandez; Francesco Marass; Prachi Nakashe; Carlos A Ruiz-Perez; Donna M Fath; Thuy Jennings; Rita Motalli-Pepio; Kate Wotrang; Angela L McCleary-Wheeler; Susan Lana; Brenda Phillips; Brian K Flesner; Nicole F Leibman; Tracy LaDue; Chelsea D Tripp; Brenda L Coomber; J Paul Woods; Mairin Miller; Sean W Aiken; Amber Wolf-Ringwall; Antonella Borgatti; Kathleen Kraska; Christopher B Thomson; Alane Kosanovich Cahalane; Rebecca L Murray; William C Kisseberth; Maria A Camps-Palau; Franck Floch; Claire Beaudu-Lange; Aurélia Klajer-Peres; Olivier Keravel; Luc-André Fribourg-Blanc; Pascale Chicha Mazetier; Angelo Marco; Molly B McLeod; Erin Portillo; Terry S Clark; Scott Judd; C Kirk Feinberg; Marie Benitez; Candace Runyan; Lindsey Hackett; Scott Lafey; Danielle Richardson; Sarah Vineyard; Mary Tefend Campbell; Nilesh Dharajiya; Taylor J Jensen; Dirk van den Boom; Luis A Diaz; Daniel S Grosu; Arthur Polk; Kalle Marsal; Susan Cho Hicks; Katherine M Lytle; Lauren Holtvoigt; Jason Chibuk; Ilya Chorny; Dana W Y Tsui
Journal:  PLoS One       Date:  2022-04-26       Impact factor: 3.752

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.